UHR-CT vs Conventional CT for Coronary Heart Disease
Trial Summary
What is the purpose of this trial?
The utility of Ultra High-Resolution Computed Tomography (UHR-CT) compared to conventional CT in all-comers (i.e., a generally lower-risk population) remains uncertain but is an important area of study in order to justify wider spread implementation and use of this technology, particularly in light of reports of significantly higher radiation exposure with UHR-CT, as well as longer scan times. The availability of technology to reconstruct conventional resolution (CR) simulation images from the raw CT acquisition data acquired on the UHR-CT scanner offers a unique platform to study this question without subjecting individuals to two different scans. The primary objective of this study is to generate preliminary data in support of the hypothesis that noninvasive UHR-CT is superior to conventional resolution CT for identifying patients with obstructive CHD.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
What data supports the effectiveness of this treatment for coronary heart disease?
Is Ultra High-Resolution CT (UHR-CT) safe for humans?
Research shows that Ultra High-Resolution CT (UHR-CT) scans provide high-quality images at moderate radiation levels, which are considered acceptable for medical imaging. Studies have demonstrated that UHR-CT can effectively capture detailed images of small structures in the body, such as blood vessels and bones, while maintaining a safe radiation dose.16789
How does Ultra High-Resolution CT differ from conventional CT for coronary heart disease?
Ultra High-Resolution CT (UHR-CT) offers improved visualization of calcified and stented vessels in the heart, which can be challenging to assess with conventional CT. This makes it particularly useful for evaluating severe coronary artery calcification, although it may result in increased noise and radiation exposure.2341011
Research Team
Joao Lima, Professor
Principal Investigator
MD
Eligibility Criteria
This trial is for individuals with various forms of heart disease, including coronary artery disease and myocardial ischemia. Participants should be generally at lower risk to assess the effectiveness of a new Ultra High-Resolution CT scan compared to conventional CT scans.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Imaging
Participants undergo CT scans using either Conventional Resolution CT or Ultra-High-Resolution CT imaging modalities
Follow-up
Participants are monitored for safety and effectiveness after imaging
Treatment Details
Interventions
- Conventional Computed Tomography
- Ultra High-Resolution Computed Tomography (UHR-CT)
Conventional Computed Tomography is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, abdominal conditions, and cancer screening
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
- Diagnostic imaging for various conditions including cardiovascular diseases, lung diseases, and abdominal conditions
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Canon Medical Systems, USA
Industry Sponsor